-
1دورية أكاديمية
المؤلفون: Hiller, LouiseAff1, Dunn, Janet A.Aff1, Loi, ShrushmaAff1, Vallier, Anne-LaureAff2, Howe, Donna L.Aff1, Cameron, David A.Aff3, Miles, DavidAff4, Wardley, Andrew M.Aff5, Earl, Helena M.Aff6, Aff7
المصدر: BMC Cancer. 18(1)
-
2
المؤلفون: Hiller, Louise, Dunn, Janet A, Loi, Shrushma, Vallier, Anne-Laure, Howe, Donna L, Cameron, David A, Miles, David, Wardley, Andrew M, Earl, Helena
مصطلحات موضوعية: Receptor, erbB-2, Treatment Outcome, Antineoplastic Agents, Immunological, Chemotherapy, Adjuvant, Surveys and Questionnaires, Humans, Breast Neoplasms, Perception, Female, Trastuzumab, Cardiotoxicity, 3. Good health
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::16158b4d4994eb153a3952b43c4ad2b4
-
3
المؤلفون: Hiller, Louise, Dunn, Janet A, Loi, Shrushma, Vallier, Anne-Laure, Howe, Donna L, Cameron, David A, Miles, David, Wardley, Andrew M, Earl, Helena M
مصطلحات موضوعية: HER2 positive, Receptor, ErbB-2, Trastuzumab cardiotoxicity, Breast Neoplasms, Trastuzumab, Cardiotoxicity, 3. Good health, Investigator questionnaire, Antineoplastic Agents, Immunological, Treatment Outcome, Chemotherapy, Adjuvant, Surveys and Questionnaires, Breast Cancer, Adjuvant trastuzumab duration, Humans, Female, Perception, skin and connective tissue diseases, neoplasms
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::eb356b8e8305cfcd483a834557a4dd36